To include your compound in the COVID-19 Resource Center, submit it here.

Allergan, Molecular Partners in ophthalmic deal

Molecular Partners AG (Schlieren, Switzerland) granted Allergan Inc. (NYSE:AGN) exclusive, worldwide rights to develop and commercialize MP0112 for

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE